| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |